1371 - 1380 of 4301 Drugs
Mononine (coagulation factor ix (human))
Mononine (coagulation factor IX human) is a clotting factor used to treat or prevent bleeding in people with hemophilia B. Mononine is not for treating people with hemophilia A factor VII deficiency. Mononine is available in generic form.
Rebinyn (coagulation factor ix (recombinant))
Rebinyn (coagulation Factor IX (recombinant), GlycoPEGylated) is a recombinant DNA-derived coagulation Factor IX concentrate indicated for use in adults and children with hemophilia B for on-demand treatment and control of bleeding episodes, and perioperative management of bleeding.
Idelvion (coagulation factor ix (recombinant) albumin fusion protein lyophilized powder intravenous injection)
Idelvion Coagulation Factor IX (Recombinant), Albumin Fusion Protein (rIX-FP) is an antihemophilic factor indicated in patients with hemophilia B (congenital FIX deficiency) or Christmas disease for routine prophylaxis to prevent or reduce the frequency of bleeding episodes, control and prevention of bleeding episodes, and control and prevention of bleeding in the perioperative setting.
Rixubis (coagulation factor ix (recombinant) for intramuscular injection)
Rixubis [Coagulation Factor IX (Recombinant)] is an antihemophilic factor used to control and prevent bleeding episodes in adults with hemophilia B, for perioperative management in adults with hemophilia B, and for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults with hemophilia B. Rixubis is not indicated for induction of immune tolerance in patients with hemophilia B.
Novoseven (coagulation factor viia (recombinant))
NovoSeven (coagulation factor Vlla recombinant) is a blood coagulant compound. NovoSeven is prescribed for the prevention and treatment of bleeding in hemophilia A or B, patients with inhibitors to Factor VIII or Factor IX, and acquired hemophilia.
Sevenfact (coagulation factor viia (recombinant)-jncw for injection)
Sevenfact [coagulation factor VIIa (recombinant)-jncw] is a coagulation factor VIIa concentrate indicated for the treatment and control of bleeding episodes occurring in adults and adolescents (12 years of age and older) with hemophilia A or B with inhibitors.
Tybost (cobicistat tablets)
Tybost (cobicistat) is a CYP3A inhibitor indicated to increase systemic exposure of atazanavir or darunavir (once daily dosing regimen) in combination with other antiretroviral agents in the treatment of HIV-1 infection.
Cotellic (cobimetinib tablets)
Cotellic (cobimetinib) is a kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, in combination with vemurafenib.
Cocaine (cocaine hydrochloride topical solution)
Cocaine (cocaine hydrochloride topical solution) is an anesthetic that works to numb the area used by health care professionals to temporarily numb the lining of the mouth, nose, and throat (mucous membranes) before certain medical procedures (e.g., biopsy, stitches, wound cleaning). Cocaine Hydrochloride Topical Solution is available in generic form.
Goprelto (cocaine hydrochloride nasal solution)
Goprelto (cocaine hydrochloride) nasal solution is an ester local anesthetic indicated for the induction of local anesthesia of the mucous membranes when performing diagnostic procedures and surgeries on or through the nasal cavities in adults.